Literature DB >> 11339786

Electroconvulsive therapy impairs systolic performance of the left ventricle.

Y Kadoi1, S Saito, S Seki, M Ide, T Morita, F Goto.   

Abstract

PURPOSE: In this observational study, we examined left ventricular systolic performance during electroconvulsive therapy (ECT), using an echocardiographic automated border detection system.
METHODS: Nine ASA I or II patients scheduled for ECT were studied. Bilateral ECT was performed after the administration of propofol 1 mg x kg(-1), succinylcholine 1 mg x kg(-1), and assisted mask ventilation with 100% oxygen. Cardiac function was monitored by transthoracic echocardiography, prior to anesthesia induction and throughout the ECT procedure until ten minutes after the seizure.
RESULTS: Increased end-systolic area and decreased fractional area change were observed at one minute after the seizure compared to the awake condition. No regional wall motion abnormalities were observed in all patients both at baseline condition and during the ECT
CONCLUSION: Systolic performance of the left ventricle estimated by echocardiography decreased transiently in the immediate period after the electric shock.

Entities:  

Mesh:

Year:  2001        PMID: 11339786     DOI: 10.1007/BF03014973

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  3 in total

1.  Effects of landiolol on left ventricular function during electroconvulsive therapy: a transthoracic echocardiographic study.

Authors:  Masanobu Ide; Yuji Kadoi; Shigeru Saito; Kenichiro Takahashi; Yukari Sawano; Masumi Miyazaki; Hitoshi Shimada
Journal:  J Anesth       Date:  2010-02-06       Impact factor: 2.078

Review 2.  Electroconvulsive therapy in the medically ill.

Authors:  Eric J Christopher
Journal:  Curr Psychiatry Rep       Date:  2003-07       Impact factor: 5.285

3.  Influence of recurrent electroconvulsive therapy on cardiac function.

Authors:  Gokay Alpak; Suleyman Ercan; Hayri Alici; Feridun Bulbul; Gokhan Altunbas; Demet Alici; Vahap Saricicek; Vedat Davutoglu
Journal:  Med Princ Pract       Date:  2014-04-16       Impact factor: 1.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.